1. Home
  2. HALO vs PLNT Comparison

HALO vs PLNT Comparison

Compare HALO & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • PLNT
  • Stock Information
  • Founded
  • HALO 1998
  • PLNT 1992
  • Country
  • HALO United States
  • PLNT United States
  • Employees
  • HALO N/A
  • PLNT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • PLNT Hotels/Resorts
  • Sector
  • HALO Health Care
  • PLNT Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • PLNT Nasdaq
  • Market Cap
  • HALO 7.4B
  • PLNT 8.1B
  • IPO Year
  • HALO N/A
  • PLNT 2015
  • Fundamental
  • Price
  • HALO $47.91
  • PLNT $97.96
  • Analyst Decision
  • HALO Buy
  • PLNT Buy
  • Analyst Count
  • HALO 9
  • PLNT 17
  • Target Price
  • HALO $63.56
  • PLNT $102.76
  • AVG Volume (30 Days)
  • HALO 3.0M
  • PLNT 1.6M
  • Earning Date
  • HALO 05-06-2025
  • PLNT 05-08-2025
  • Dividend Yield
  • HALO N/A
  • PLNT N/A
  • EPS Growth
  • HALO 55.40
  • PLNT 21.55
  • EPS
  • HALO 3.76
  • PLNT 2.11
  • Revenue
  • HALO $1,084,306,000.00
  • PLNT $1,129,218,000.00
  • Revenue This Year
  • HALO $24.79
  • PLNT $20.79
  • Revenue Next Year
  • HALO $22.65
  • PLNT $9.98
  • P/E Ratio
  • HALO $13.36
  • PLNT $46.53
  • Revenue Growth
  • HALO 25.64
  • PLNT 10.26
  • 52 Week Low
  • HALO $41.28
  • PLNT $59.16
  • 52 Week High
  • HALO $70.51
  • PLNT $110.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 32.31
  • PLNT 53.23
  • Support Level
  • HALO $58.38
  • PLNT $92.78
  • Resistance Level
  • HALO $69.94
  • PLNT $102.92
  • Average True Range (ATR)
  • HALO 3.37
  • PLNT 3.29
  • MACD
  • HALO -1.11
  • PLNT -0.07
  • Stochastic Oscillator
  • HALO 1.78
  • PLNT 52.54

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

Share on Social Networks: